Evidence map›Paper›PMID 32629197›Full record

SynthesisPsychiatry research. Neuroimaging2020

The neurobiological reward system in Prolonged Grief Disorder (PGD): A systematic review.

S E Kakarala, K E Roberts, M Rogers, T Coats, F Falzarano, J Gang, M Chilov, J Avery, P K Maciejewski, W G Lichtenthal and 1 more

2 registry-linked trialsOpen access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Psychiatry research. Neuroimaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04547985 phase4terminatednot on this mapstarted 2021, after this paper: background citation

Naltrexone Treatment for Prolonged Grief Disorder: A Pilot Study

TypeinterventionalSponsorWeill Medical College of Cornell UniversityRan2021 to 2023Enrolled9ConditionsProlonged Grief DisorderArmsNaltrexone HCl 50 MG Oral Tablet, Placebo
NCT06140420 phase4terminatednot on this mapstarted 2023, after this paper: background citation

Naltrexone Treatment for Prolonged Grief Disorder: A Proof of Concept Study

TypeinterventionalSponsorTexas Tech UniversityRan2023 to 2025Enrolled7ConditionsNaltrexone HCl 50 MG Oral Tablet, PlaceboArmsNaltrexone Oral Product, Placebo
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Prolonged grief disorder in later life: advancing our understanding of biopsychosocial mechanisms to guide future personalized interventions.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Prolonged Grief Disorder: Addressing Misconceptions With Evidence.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

S E KakaralaCornell Center for Research on End-of-life Care, Weill Cornell Medicine, 420 E. 70th St., New York, NY 10021, USA.
K E RobertsDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY 10065, USA.
M RogersCornell Center for Research on End-of-life Care, Weill Cornell Medicine, 420 E. 70th St., New York, NY 10021, USA.
T CoatsDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY 10065, USA.
F FalzaranoCornell Center for Research on End-of-life Care, Weill Cornell Medicine, 420 E. 70th St., New York, NY 10021, USA.
J GangCornell Center for Research on End-of-life Care, Weill Cornell Medicine, 420 E. 70th St., New York, NY 10021, USA.
M ChilovMedical Library, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY 10065, USA.
J AveryDepartment of Radiology, Weill Cornell Medicine, 1305 York Ave., New York, NY 10021, USA.
P K MaciejewskiCornell Center for Research on End-of-life Care, Weill Cornell Medicine, 420 E. 70th St., New York, NY 10021, USA; Department of Radiology, Weill Cornell Medicine, 1305 York Ave., New York, NY 10021, USA.
W G LichtenthalDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY 10065, USA; Department of Psychiatry, Weill Cornell Medicine, 525 E. 68th St., New York, NY 10065, USA.
H G PrigersonCornell Center for Research on End-of-life Care, Weill Cornell Medicine, 420 E. 70th St., New York, NY 10021, USA; Department of Medicine, Weill Cornell Medicine, 1320 York Ave., New York, NY 10021, USA. Electronic address: hgp2001@med.cornell.edu.
Cornell University · USMemorial Sloan Kettering Cancer Center · USWeill Cornell Medicine · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
Pilot CoreP30AG022845 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Manney Carrington Reid · 2003 to 2026
$15.2M
Psychosocial Approaches to Better Understanding & End-Stage Cancer Care (PROTECT)R35CA197730 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Holly Gwen Prigerson · 2015 to 2026
$11.2M
Psychosocial Palliative & Community Research in CancerT32CA009461 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI JENNIFER L HAY, Jamie S. Ostroff · 1985 to 2026
$10.1M
Quality of Death: Ethnic and Psychosocial InfluencesR01CA106370 · NCI · YALE UNIVERSITY · PI PRIGERSON, HOLLY GWEN · 2004 to 2015
$4.1M
The Weill Cornell Medicine Research Training Program in Behavioral GeriatricsT32AG049666 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SARA J CZAJA, Manney Carrington Reid · 2016 to 2026
$3.2M
Latino vs. Non-Latino Disparities in Advance Care Planning & End-of-Life CareR01MD007652 · NIMHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI MACIEJEWSKI, PAUL K, PRIGERSON, HOLLY GWEN · 2014 to 2018
$1.9M
Psychiatric Disorder in Dying Patients &Their SurvivorsR01MH063892 · NIMH · YALE UNIVERSITY · PI JACOBS, SELBY C · 2002 to 2005
$1.9M
An Investigation of the Clinical Utility of a Prolonged Grief Disorder DiagnosisR21MH095378 · NIMH · SLOAN-KETTERING INST CAN RESEARCH · PI LICHTENTHAL, WENDY G., PRIGERSON, HOLLY GWEN · 2013 to 2014
$504k
Communicating the Gist of Prognosis: Giving Information Simply and Transparently ("GIST") in Advanced CancerR21NR018693 · NINR · WEILL MEDICAL COLL OF CORNELL UNIV · PI EPSTEIN, ANDREW, PRIGERSON, HOLLY GWEN · 2019 to 2020
$488k
Automated Detection of Suicide Attempt Risk among Bereaved IndividualsR21MH121886 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI MACIEJEWSKI, PAUL K, PRIGERSON, HOLLY GWEN · 2020 to 2021
$454k
NCATS NIH HHS UL1 TR002384NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA106370NCI NIH HHS R21 CA218313NCI NIH HHS R35 CA197730NCI NIH HHS T32 CA009461NIA NIH HHS P30 AG022845NIA NIH HHS T32 AG049666NIMHD NIH HHS R01 MD007652NIMH NIH HHS R01 MH063892NIMH NIH HHS R21 MH095378NIMH NIH HHS R21 MH121886NINR NIH HHS R21 NR018693
6 · The paper itself

Abstract

Prolonged Grief Disorder (PGD) is a debilitating condition affecting between 7% and 10% of bereaved individuals. Past imaging and psychological studies have proposed links between PGD's characteristic symptoms - in particular, profound yearning - and the neural reward system. We conducted a systematic review to investigate this connection. On December 19, 2019, we searched six bibliographic databases for data on the neurobiology of grief and disordered grief. We excluded studies of the hypothalamic-pituitary-adrenal (HPA) axis, animal studies, and reviews. After abstract and full-text screening, twenty-four studies were included in the final review. We found diverse evidence for the activation of several reward-related regions of the brain in PGD. The data reviewed suggest that compared to normative grief, PGD involves a differential pattern of activity in the amygdala and orbitofrontal cortex (OFC); likely differential activity in the posterior cingulate cortex (PCC), rostral or subgenual anterior cingulate cortex (ACC), and basal ganglia overall, including the nucleus accumbens (NAc); and possible differential activity in the insula. It also appears that oxytocin signaling is altered in PGD, though the exact mechanism is unclear. Our findings appear to be consistent with, though not confirmative of, conceptualizing PGD as a disorder of reward, and identify directions for future research.

Indexed as

GriefRewardBereavementBrainHumansTime FactorsBereavementComplicated Grief (CG)NeuroimagingNneurobiologyProlonged Grief Disorder (PGD)

Identifiers

PMID32629197
PMCPMC7442719
OpenAlexW3040354786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.